¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"low ionic strenglh salt solution"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • double salt
    °ã¿°, º¹¿°
  • mineral salt
    ¹«±â¿°
  • neutral salt
    Áß¼º¿°
  • stannous salt
    Á¦ÀÏÁÖ¼®¿°
  • salt
    1. ¿° 2. ¼Ò±Ý
  • salt depletion
    ¿°·ù»ó½Ç, ¿°·ù°í°¥
  • salt-and-pepper fundus
    ÈÄÃ߼ұݸð¾ç¾ÈÀú, ÈÄÃ߼ұݸð¾ç´«¹Ù´Ú
  • salt-losing nephritis
    ¿°¼Ò¸ðÄáÆÏ¿°, ¿°¼Ò¸ð½ÅÀå¿°
  • low back pain
    Ç㸮ÅëÁõ, ¿äÅë
  • low birth weight infant
    ÀúüÁßÃâ»ý¾Æ
  • low cervical cesarean section
    ¾Æ·¡ÀڱøñÁ¦¿ÕÀý°³(¼ú), ÇϺÎÀڱðæºÎÁ¦¿ÕÀý°³(¼ú)
  • low density lipoprotein
    Àú¹ÐµµÁöÁú´Ü¹éÁú
  • low dose rate
    Àú¼±·®·ü
  • low dose rate irradiation
    Àú¼±·®·üÁ¶»ç
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Lugol's solution
    ·ç°ñ¿ë¾×
  • Ringer's lactate solution
    ¸µ°ÅÁ¥»ê¿ë¾×
  • saturated solution
    Æ÷È­¿ë¾×
  • stock solution
    ¿ø¾×
  • stop solution
    Á¤Áö¾×
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • lyotropic ionic series
    À̾×À̿°迭
  • acid salt
    »ê¼º¿°
  • alkali salt
    ¾ËÄ®¸®¿°
  • bile salt
    ´ãÁó»ê¿°
  • Carlsbad salt
    Ä«¸¦½ºÃµ¿°
  • double salt
    °ã¿°, º¹¿°
  • salt-and-pepper fundus
    ÈÄÃ߼ұݸð¾ç¾ÈÀú, ÈÄÃ߼ұݸð¾ç´«¹Ù´Ú
  • mineral salt
    ¹«±â¿°
  • neutral salt
    Áß¼º¿°
  • salt
    ¿°
  • stannous salt
    Á¦ÀÏÁÖ¼®¿°
  • low echo area
    ³·Àº¸Þ¾Æ¸®¿µ¿ª, Àú¿¡ÄÚ¿µ¿ª
  • low vision aid
    Àú½Ã·Âº¸Á¶±â
  • low pressure chamber
    Àú¾Ð½Ç
  • low forceps delivery
    ÀúÀ§Áý°ÔºÐ¸¸¼ú
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Chameleon solution
    Ä«¸á·¹¿Â¿ë¾×.
  • Channings solution
    Âù´×¾×.
  • Chenzinsky-Plein solution
    þÁø½ºÅ²-Ç÷¹Àο°»ö¾×.
  • Earies solution
    Earle¿ë¾×
  • Fowlers solution
    ÆÄ¿ï·¯ ¾×
  • Hanks solution
    ÇÚÅ©¿ë¾×
  • Hanks solution
    ÇàÅ© ÆòÇü¿°¿ë¾×
  • Hartmann s hypotonic solution
    Çϸ£Æ®¸¸ÀúÀå¾×.
  • Hayem s solution
    ¾ÆÀ̾ä¿ë¾×.
  • Heidenhain s hematoxylin staining solution
    ÇÏÀ̵§ÇÏÀÎ Ç츶Åå½Ç¸° ¿°»ö¾×.
  • Locke s solution
    ·ÎÅ©¾×.
  • Lockes solution
    ·ÎÅ©¾×
  • Lockes solution
    ·ÎÅ©¾×(¡­äû).
  • Lugols solution
    ·ç°ñ¾× (±×¶÷¿°»ö¿ë ¸Å¿°Á¦)
  • Ringer s solution
    ¸µ°Å¾×.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • ionic conduction
    ÀÌ¿ÂÀüµµ.
  • ionic conductivity
    ÀÌ¿ÂÀüµµµµ<·Â>.
  • ionic current
    ÀÌ¿ÂÀü·ù(¡­ï³êü).
  • ionic emulsifying agent
    ÀÌ¿ÂÀ¯È­Á¦ (¡­êáûùð¥).
  • ionic equation
    À̿½Ä(¡­ãÒ).
  • ionic exchange
    À̿±³È¯(¡­Îßüµ).
  • ionic linkage
    À̿°áÇÕ(¡­Ì¿ùê).
  • ionic permeability
    ÀÌ¿ÂÅõ°ú¼º(¡­÷âΦàõ).
  • ionic polarization
    À̿ºбØ(¡­ÝÂп).
  • ionic polymerization
    ÀÌ¿ÂÁßÇÕ(¡­ñìùê).
  • ionic product
    ÀÌ¿ÂÀû(¡­îÝ), À̿»깰.
  • ionic reaction
    À̿¹ÝÀÀ(Úãëë).
  • ionic regulation
    ÀÌ¿ÂÁ¶Àý.
  • ionic strength
    À̿°­µµ
  • ionic strength
    À̿°­µµ(Ë­Óø).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • low background counter
    ³·Àº¹ÙÅÁ °è¼ö±â(ͪâ¦Ðï)
  • low-copy number
    Àú(î¸)Ä«ÇǼö(â¦)
  • low-density fraction
    Àú¹ÐµµºÐȹ(î¸ÚËÓøÝÂüñ)
  • low-density lipoprotein
    Àú¹Ðµµ Áö´Ü¹éÁú(î¸ÚËÓøò·Ó±ÛÜòõ)
  • low-energy compound
    Àú(î¸)¿¡³ÊÁöÈ­ÇÕ¹°(ûùùêÚª)
  • low-energy electron diffraction
    Àú(î¸)¿¡³ÊÁö ÀüÀÚȸÀý(ï³í­üÞï¹)
  • low-energy ion scattering
    Àú(î¸)¿¡³ÊÁö À̿ºлê(ÝÂߤ)
  • low-energy phophate acceptor
    Àú(î¸)¿¡³ÊÁö Àλê¼ö³³Ã¼(×òß«áôÒ¡ô÷)
  • low-frequency transduction
    Àúºóµµ ÇüÁúµµÀÔ(î¸ÞºÓøû¡òõÓôìý)
  • low-level promoter
    ÀúÀ§(î¸êÈ) ÇÁ·Î¸ðÅÍ
  • low-lipid lipoprotein
    ÀúÁöÁú Áö´Ü¹éÁú(î¸ò·òõò·Ó±ÛÜòõ)
  • low-order antibody
    ÀúÂ÷Ç×ü(î¸ó­ù÷ô÷)
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • low-quality protein
    ÀúÁú´Ü¹éÁú(î¸òõÓ±ÛÜòõ)
  • low-speed sedimentaion equilibrium
    Àú¼Óħ°­ÆòÇü(î¸áÜöØË½øÁû¬)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • low intensity void in proton flow
    ¾ç¼ºÀÚÈ帧ÀÇ Àú°­µµ¼Ò½Ç
  • low pass filter
    ÀúÅë°ú¿©°ú±â
  • low signal
    Àú½ÅÈ£
  • low signal intensity
    Àú½ÅÈ£°­µµ
  • ultra low field MR scanner
    ÃÊÀúÀÚÀåÀÚ±â°ø¸í½ºÄ³³Ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
EBSS Earle's balanced salt solution
HBSS Hank's balanced salt solution
MHBSS modified Hank balanced salt solution
SA salicylic acid; saline [solution]; salt added; sarcoidosis; sarcoma; scalenus anticus; secondary ame...
SBSS Seligmann's buffered salt solution
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PSS K(+)-physiological salt solution
SSS Salt Sugar Solution
PSS physiologic salt solution
Ii Ionic
IS Ionic Strength
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • low birth weight
    ÀúüÁß Ãâ»ý
  • low carat gold alloy
    ÀúÄ«¶óÆ® ±Ý ÇÕ±Ý
    16Ä«¶óÆ® ÀÌÇÏÀÇ ±Ý ÇÕ±Ý. ³³Âø ÇÕ±ÝÀ» ¸»ÇÑ´Ù.
  • low copper amalgam
    Àú µ¿ ¾Æ¸»°¨
  • low frequency
    ÀúÁÖÆÄ
    Á֯ļö°¡ ³·Àº ÆÄ. Áï, ÀüÀÚ±âÆÄÀÇ Á֯ļö¿¡ ÀÇÇÑ ºÐ·ù·Î¼­, º¸Åë 10 kHz ÀÌÇϸ¦ ¸»ÇÑ´Ù. ¿Àµð¿À
  • low frequency therapeutic apparatus
    ÀúÁÖÆÄ Ä¡·á±â
  • low fusing porcelain
    Àú¿Â ¿ëÀ¶ µµÀç
    Ä¡°ú¿ë µµÀçÀÇ Á¾·ùÀε¥ 1600¡Æ¡­2000¢µ¿¡¼­ 󸮵Ǵ µµÀçÀÌ´Ù.
  • low lip line
    Çϼø ¼±
    ÀÔÀ» °íÀÇ·Î Å©°Ô ¹ú¸®°Å³ª ¶Ç´Â ¿ôÀ» ¶§¿¡ À§Ä¡ÇÏ´Â ÃÖÇÏÀ§ÀÇ À§Ä¡¸¦ ¶æÇÒ ¶§µµ ÀÖ°í, »ó¼øÀÌ Á¤Áö »óÅ¿¡ ÀÖÀ» ¶§ ±× ÇÏ¿¬´ÜÀ» °¡¸®Å°±âµµ ÇÑ´Ù.
  • low output syndrome
    Àú ¹ÚÃâ·® ÁõÈıº
  • low pressure hydrocephalus
    Àú¾Ð¼º ¼öµÎÁõ
  • low silver amalgam
    ÀúÀº ¾Æ¸»°¨
  • low temperature
    Àú¿Â
  • low voltage
    Àú Àü¾Ð
  • low-density lipoprotein
    Àú¹Ðµµ Áö¹æ ´Ü¹é
  • low-frequency wave
    ÀúÁÖÆÄ
  • low-pitched
    ³»¸®±î´Â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
heparin, low-molecular-weight <chemical> Heparin fractions with a molecular weight usually between 4000 and 6000 kD. These low-molecular-weight fractions are effective antithrombotic agents. Their administration reduces the risk of haemorrhage, they have a longer half-life, and their platelet interactions are reduced in comparison to unfractionated heparin. They also provide an effective prophylaxis against postoperative major pulmonary embolism.
Pharmacological action: anticoagulant, fibrinolytic agent.
(12 Dec 1998)
infant, low birth weight An infant having a birth weight of 2500 gm. (5.5 lb.) or less but infant, very low birth weight is available for infants having a birth weight of 1500 grams (3.3 lb.) or less.
(12 Dec 1998)
infant, very low birth weight An infant having a birth weight of 1500 grams (3.3 lb.) or less.
(12 Dec 1998)
ear, low-set A minor anomaly involving an ear situated down below its normal location. Technically, the ear is low-set when the helix (of the ear) meets the cranium at a level below that of a horizontal plane through both inner canthi (the inside corners of the eyes). The presence of 2 or more minor anomalies in a child increases the probability that the child has a major malformation.
(12 Dec 1998)
kininogen, low-molecular-weight A protein, molecular weight 50 kD, located in various normal tissues. Upon cleavage by kallikrein or other kallikreins, it forms kallidin. Kallidin, in turn, is converted into bradykinin.
(12 Dec 1998)
low 1. Occupying an inferior position or place; not high or elevated; depressed in comparison with something else; as, low ground; a low flight.
2. Not rising to the usual height; as, a man of low stature; a low fence.
3. Near the horizon; as, the sun is low at four o'clock in winter, and six in summer.
4. Sunk to the farthest ebb of the tide; as, low tide.
5. Beneath the usual or remunerative rate or amount, or the ordinary value; moderate; cheap; as, the low price of corn; low wages.
6. Not loud; as, a low voice; a low sound.
7. Depressed in the scale of sounds; grave; as, a low pitch; a low note.
8. Made, as a vowel, with a low position of part of the tongue in relation to the palate; as, (m), (all).
9. Near, or not very distant from, the equator; as, in the low northern latitudes.
10. Numerically small; as, a low number.
11. Wanting strength or animation; depressed; dejected; as, low spirits; low in spirits.
12. Depressed in condition; humble in rank; as, men of low condition; the lower classes. "Why but to keep ye low and ignorant ?" (Milton)
13. Mean; vulgar; base; dishonorable; as, a person of low mind; a low trick or stratagem.
14. Not elevated or sublime; not exalted or diction; as, a low comparison. "In comparison of these divine writers, the noblest wits of the heathen world are low and dull." (Felton)
15. Submissive; humble. "Low reverence."
16. Deficient in vital energy; feeble; weak; as, a low pulse; made low by sickness.
17. Moderate; not intense; not inflammatory; as, low heat; a low temperature; a low fever.
18. Smaller than is reasonable or probable; as, a low estimate.
19. Not rich, high seasoned, or nourishing; plain; simple; as, a low diet.
Low is often used in the formation of compounds which require no special explanation; as, low-arched, low- browed, low-crowned, low-heeled, low-lying, low-priced, low-roofed, low-toned, low-voiced, and the like. Low Church. See High Church, under High. Low Countries, the Netherlands. Low German, Low Latin, etc. See German, Latin, etc. Low life, humble life. Low milling, a process of making flour from grain by a single grinding and by siftings. Low relief. See Bas-relief.
<medicine> Low side window, a contrivance of various forms attached to a boiler for giving warning when the water is low. Low water mark, that part of the shore to which the waters recede when the tide is the lowest. Low wine, a liquor containing about 20 percent of alcohol, produced by the first distillation of wash; the first run of the still; often in the plural.
Origin: OE. Low, louh, lah, Icel. Lagr; akin to Sw. Lag, Dan. Lav, D. Laag, and E. Lie. See Lie to be prostrate.
1. In a low position or manner; not aloft; not on high; near the ground.
2. Under the usual price; at a moderate price; cheaply; as, he sold his wheat low.
3. In a low mean condition; humbly; meanly.
4. In time approaching our own. "In that part of the world which was first inhabited, even as low down as Abraham's time, they wandered with their flocks and herds." (Locke)
5. With a low voice or sound; not loudly; gently; as, to speak low. "The . . . Odourous wind Breathes low between the sunset and the moon." (Tennyson)
6. With a low musical pitch or tone. "Can sing both high and low." (Shak)
7. In subjection, poverty, or disgrace; as, to be brought low by oppression, by want, or by vice.
8. <astronomy> In a path near the equator, so that the declination is small, or near the horizon, so that the altitude is small; said of the heavenly bodies with reference to the diurnal revolution; as, the moon runs low, that is, is comparatively near the horizon when on or near the meridian.
Source: Websters Dictionary
(01 Mar 1998)
low-activation materials <radiobiology> In fission reactors, one is forced to deal with the radioactive byproducts of the fission process, but in fusion reactors one generally has a choice of what materials to expose to neutrons produced by the fusion process. A major problem for fusion reactors is developing materials (such as for the reactor vacuum vessel structure) which can be exposed to high levels of neutron bombardment without becoming permanently radioactive. Candidate structural materials which have relatively low induced radiactivation (generally relative to stainless steel) are known as low-activation materials, these include titanium, vanadium, and silicon-carbide.
(09 Oct 1997)
low affinity platelet factor IV Cytokine, produced from platelet basic protein, that acts as a growth factor.
(18 Nov 1997)
low aspect ratio <physics> An aspect ratio for a torus that is small (minor radius is almost as big as major radius).
There are many fusion devices which are designed to have a low aspect ratio. Such devices look more like tractor tires than bicycle tires, as toruses go. There are reasons to believe that low aspect ratio devices will offer some advantages for a fusion reactor. Usually, ease of theoretical and/or numerical analysis is not one of these advantages.
(16 Mar 1998)
low back pain A continuous pain in the lower back or lumbar region.
(12 Dec 1998)
low-calorie diet A diet of 1,200 calories or less per day.
(05 Mar 2000)
low convex The segment of a sphere of long radius.
(05 Mar 2000)
low delirium Delirium in which there is little excitement, either mental or motor, the ideas being confused and incoherent, but following each other slowly.
(05 Mar 2000)
low density lipoprotein <biochemistry> A lipoprotein substances (combination of a fat and a protein) which acts as a carrier for cholesterol and fats in the bloodstream.
High levels of low density lipoprotein are considered a positive risk factor for the development of coronary artery disease. Less than 130 mg/dl is desirable, 130 to 159 mg/dl is borderline high, over 160 is considered high.
Acronym: LDL
(10 Jan 1998)
low density lipoprotein receptor <biochemistry> A cell surface protein that mediates the endocytosis of low density lipoprotein by cells.
Genetic defects in low density lipoprotein receptors lead to abnormal serum levels of low density lipoprotein and hypercholesterolaemia.
(16 Mar 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Great Salt Lake
    ¹Ì±¹ Utah ÁÖ¿¡ ÀÖ´Â ¾èÀº ÇÔ¼öÈ£
  • Rochelle salt
    ·Î¼Ð¿°(ÁÖ¼®»ê Ä®·ý³ªÆ®·ýÀ¸·Î¼­ ¿ÏÇÏÁ¦)
  • SALT
    Strategic Arms Limitation Talks Àü·« ¹«±â Á¦ÇÑ ÇùÁ¤
  • Salt Lake City
    ¹Ì±¹ UtahÁÖÀÇ Á¶µµ;Mormmon±³ÀÇ ¸ÞÄ«
  • double salt
    (È­)º¹¿°
  • microcosmic salt
    Àο°
  • rock salt
    ¾Ï¿°(mineral salt)
  • salt
    ¼Ò±Ý;½Ä¿°;ÀÚ±Ø;Èï¹Ì;dzÀÚ;±âÁö;½ÄŹ¿ë ¼Ò±Ý ±×¸©;(³ë·ÃÇÑ) ¹î»ç¶÷;eat a person's ~;...ÀÇ ¼Õ´ÔÀÌ µÇ´Ù;in ~ ¼Ò±ÝÀ» Ä£;¼Ò±Ý¿¡ ÀýÀÎ
  • salt lick
    Áü½ÂÀÌ ¼Ò±ÝÀ» ÇÓÀ¸·¯ ¿À´Â °÷(¸»¶óºÙÀº ¿°È£ µûÀ§)
  • salt mine
    ¿°°»
  • table salt
    ½ÄŹ¿ë ¼Ò±Ý
  • low
    ³·Àº,³·°Ô,õÇϰÔ,(¼Ò°¡)¿ï´Ù
  • low-minded
    ºñ¿­ÇÑ
  • Low Church
    Àú±³È¸ÆÄ(¿µ±¹ ±¹±³ÆÄÁß,±³È¸ÀÇ ±³¸®,ÀǽĿ¡ ÁßÁ¡À» µÎÁö ¾Ê´Â ÇÑ ÆÄ)
  • Low Churchman
    Àú±³È¸ÆÄÀÇ »ç¶÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á